Cargando…
Diffusion-free valve for preprogrammed immunoassay with capillary microfluidics
By manipulating the geometry and surface chemistry of microfluidic channels, capillary-driven microfluidics can move and stop fluids spontaneously without external instrumentation. Furthermore, complex microfluidic circuits can be preprogrammed by synchronizing the capillary pressures and encoding t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352302/ https://www.ncbi.nlm.nih.gov/pubmed/37469685 http://dx.doi.org/10.1038/s41378-023-00568-2 |
_version_ | 1785074483491504128 |
---|---|
author | Azizian, Pooya Casals-Terré, Jasmina Ricart, Jordi Cabot, Joan M. |
author_facet | Azizian, Pooya Casals-Terré, Jasmina Ricart, Jordi Cabot, Joan M. |
author_sort | Azizian, Pooya |
collection | PubMed |
description | By manipulating the geometry and surface chemistry of microfluidic channels, capillary-driven microfluidics can move and stop fluids spontaneously without external instrumentation. Furthermore, complex microfluidic circuits can be preprogrammed by synchronizing the capillary pressures and encoding the surface tensions of microfluidic chips. A key component of these systems is the capillary valve. However, the main concern for these valves is the presence of unwanted diffusion during the valve loading and activation steps that can cause cross-contamination. In this study, we design and validate a novel diffusion-free capillary valve: the π-valve. This valve consists of a 3D structure and a void area. The void acts as a spacer between two fluids to avoid direct contact. When the valve is triggered, the air trapped within the void is displaced by pneumatic suction induced from the capillary flow downstream without introducing a gas bubble into the circuit. The proposed design eliminates diffusive mixing before valve activation. Numerical simulation is used to study the function and optimize the dimensions of the π-valve, and 3D printing is used to fabricate either the mould or the microfluidic chip. A comparison with a conventional valve (based on a constriction-expansion valve) demonstrates that the π-valve eliminates possible backflow into the valve and reduces the mixing and diffusion during the loading and trigger steps. As a proof-of-concept, this valve is successfully implemented in a capillary-driven circuit for the determination of benzodiazepine, achieving the successive release of 3 solutions in a 3D-printed microfluidic chip without external instrumentation. The results show a 40% increase in the fluorescence intensity using the π-valve relative to the conventional value. Overall, the π-valve prevents cross-contamination, minimizes sample use, and facilitates a sophisticated preprogrammed release of fluids, offering a promising tool for conducting automated immunoassays applicable at point-of-care testing. [Image: see text] |
format | Online Article Text |
id | pubmed-10352302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103523022023-07-19 Diffusion-free valve for preprogrammed immunoassay with capillary microfluidics Azizian, Pooya Casals-Terré, Jasmina Ricart, Jordi Cabot, Joan M. Microsyst Nanoeng Article By manipulating the geometry and surface chemistry of microfluidic channels, capillary-driven microfluidics can move and stop fluids spontaneously without external instrumentation. Furthermore, complex microfluidic circuits can be preprogrammed by synchronizing the capillary pressures and encoding the surface tensions of microfluidic chips. A key component of these systems is the capillary valve. However, the main concern for these valves is the presence of unwanted diffusion during the valve loading and activation steps that can cause cross-contamination. In this study, we design and validate a novel diffusion-free capillary valve: the π-valve. This valve consists of a 3D structure and a void area. The void acts as a spacer between two fluids to avoid direct contact. When the valve is triggered, the air trapped within the void is displaced by pneumatic suction induced from the capillary flow downstream without introducing a gas bubble into the circuit. The proposed design eliminates diffusive mixing before valve activation. Numerical simulation is used to study the function and optimize the dimensions of the π-valve, and 3D printing is used to fabricate either the mould or the microfluidic chip. A comparison with a conventional valve (based on a constriction-expansion valve) demonstrates that the π-valve eliminates possible backflow into the valve and reduces the mixing and diffusion during the loading and trigger steps. As a proof-of-concept, this valve is successfully implemented in a capillary-driven circuit for the determination of benzodiazepine, achieving the successive release of 3 solutions in a 3D-printed microfluidic chip without external instrumentation. The results show a 40% increase in the fluorescence intensity using the π-valve relative to the conventional value. Overall, the π-valve prevents cross-contamination, minimizes sample use, and facilitates a sophisticated preprogrammed release of fluids, offering a promising tool for conducting automated immunoassays applicable at point-of-care testing. [Image: see text] Nature Publishing Group UK 2023-07-17 /pmc/articles/PMC10352302/ /pubmed/37469685 http://dx.doi.org/10.1038/s41378-023-00568-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Azizian, Pooya Casals-Terré, Jasmina Ricart, Jordi Cabot, Joan M. Diffusion-free valve for preprogrammed immunoassay with capillary microfluidics |
title | Diffusion-free valve for preprogrammed immunoassay with capillary microfluidics |
title_full | Diffusion-free valve for preprogrammed immunoassay with capillary microfluidics |
title_fullStr | Diffusion-free valve for preprogrammed immunoassay with capillary microfluidics |
title_full_unstemmed | Diffusion-free valve for preprogrammed immunoassay with capillary microfluidics |
title_short | Diffusion-free valve for preprogrammed immunoassay with capillary microfluidics |
title_sort | diffusion-free valve for preprogrammed immunoassay with capillary microfluidics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352302/ https://www.ncbi.nlm.nih.gov/pubmed/37469685 http://dx.doi.org/10.1038/s41378-023-00568-2 |
work_keys_str_mv | AT azizianpooya diffusionfreevalveforpreprogrammedimmunoassaywithcapillarymicrofluidics AT casalsterrejasmina diffusionfreevalveforpreprogrammedimmunoassaywithcapillarymicrofluidics AT ricartjordi diffusionfreevalveforpreprogrammedimmunoassaywithcapillarymicrofluidics AT cabotjoanm diffusionfreevalveforpreprogrammedimmunoassaywithcapillarymicrofluidics |